Ligand has assembled one of the largest portfolios of biopharmaceutical assets among our peers which provides investors the opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company.
Program | Partner | Indication | Technology | Development Stage | ||||
---|---|---|---|---|---|---|---|---|
Preclinical | Phase 1 | Phase 2 | Phase 3 or Regulatory | Approved | ||||
Carnexiv | Lundbeck | CNS | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Vfend-IV | Pfizer | Infectious Disease | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Posaconazole | Par Pharmaceuticals | Infectious Disease | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Aziyo Base Business | Aziyo | Medical Device | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Cangaroo Envelope | Aziyo | Medical Device | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Promacta | Novartis | Blood Disorders | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Duavee | Pfizer | Inflammatory/Metabolic | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Viviant/Conbriza | Pfizer | Inflammatory/Metabolic | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Baxdela | Melinta | Infectious Disease | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Exemptia | Zydus Cadila | Inflammatory/Metabolic | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Bryxta | Zydus Cadila | Oncology | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Evomela | Spectrum | Oncology | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Kyprolis | Amgen | Oncology | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Voriconazole | Hikma | Infectious Disease | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Voriconazole | Alvogen | Infectious Disease | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Noxafil-IV | Merck | Infectious Disease | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Vivitra | Zydus Cadila | Oncology | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
Nexterone | Baxter | Cardiovascular | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory Complete
|
Approved In Progress
|
CHS-0214 | Coherus | Inflammatory/Metabolic | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory In Progress
|
Approved Not Started
|
CE-Fosphenytoin | Sedor | CNS | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory In Progress
|
Approved Not Started
|
Brexanolone | SAGE | CNS | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory In Progress
|
Approved Not Started
|
Pevonedistat | Takeda | Oncology | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory In Progress
|
Approved Not Started
|
BCD-066 | Biocad | Blood Disorders | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory In Progress
|
Approved Not Started
|
CS-3150 | Exelixis/Daiichi-Sankyo | Cardiovascular | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory In Progress
|
Approved Not Started
|
ONS-3010 | Oncobiologics | Oncology | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory In Progress
|
Approved Not Started
|
ONS-1045 | Oncobiologics | Oncology | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 Complete
|
Phase 3 or Regulatory In Progress
|
Approved Not Started
|
MM-141 | Merrimack Pharma | Oncology | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Reproxalap | Aldeyra Therapeutics | Other/Undisclosed | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Lasofoxifene | Sermonix | Inflammatory/Metabolic | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OPT-302 | Opthea Ltd | Other/Undisclosed | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
MM-121 | Merrimack Pharma | Oncology | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Ganaxalone IV | Marinus Pharma | CNS | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
GS-5734 | Gilead | Infectious Disease | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Aplindore | Seelos | CNS | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Ensituximab | Precision Biologics | Oncology | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Lubricin | Novartis | Oncology | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
VK5211 | Viking | Inflammatory/Metabolic | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
VTX-2337 | VentiRx Pharma | Oncology | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
VK0612 | Viking | Inflammatory/Metabolic | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
hCDR1 | XTL Bio | Cardiovascular | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
KLM465 | Novartis | Blood Disorders | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Merestinib | Eli Lilly | Oncology | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
TR Beta | Viking | Inflammatory/Metabolic | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Prexasertib | Eli Lilly | Oncology | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Sparsentan | Retrophin | Cardiovascular | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
BMS986231 | BMS | Cardiovascular | Captisol |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
RVT-1502 | Roivant | Inflammatory/Metabolic | Other/NCE |
Preclinical Complete
|
Phase 1 Complete
|
Phase 2 In Progress
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OPC-108459 | Otsuka | Cardiovascular | Captisol |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
GNR-008 | IBC Generium | Cardiovascular | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Pradefovir | Chiva Pharma | Infectious Disease | Other/NCE |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Cudafol | Cuda Pharma | CNS | Captisol |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
CXCR4 | Upsher-Smith | Oncology | Other/NCE |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
TAK-020 | Takeda | Inflammatory/Metabolic | Captisol |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Mekinist POS | Novartis | Oncology | Captisol |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
anti-FcRN | Hanall | Inflammatory/Metabolic | OmniAb |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
PCSK-9 | Genekey Biotech | Inflammatory/Metabolic | OmniAb |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
RGB-03 | Gedeon Richter | Inflammatory/Metabolic | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
IV Topiramate | CURx Pharma | CNS | Captisol |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
VTX-1463 | VentiRx Pharma | Oncology | Captisol |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
F-102 | F-Star | Oncology | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
MB07133 | Chiva Pharma | Oncology | Other/NCE |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
AMG-330 | Amgen | Oncology | Captisol |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
ML-061 | Meridian | Oncology | Captisol |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Trastuzumab | Gedeon Richter | Oncology | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
PDL-1 | C-Stone | Oncology | OmniAb |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
PD-1 | Gloria | Oncology | OmniAb |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
BCMAxCD3 | Janssen | Oncology | OmniAb |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
JPH-203 (Injection) | J-Pharma | Oncology | Captisol |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Deplera | IBC Generium | Oncology | Selexis SUREtechnology |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
ME-344 | MEI Pharma | Oncology | Captisol |
Preclinical Complete
|
Phase 1 In Progress
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
IRAK4 | TG Therapeutics | Oncology | Other/NCE |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Lasofoxifene | Azure | Inflammatory/Metabolic | Other/NCE |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
anti-FcRN | Roivant | Inflammatory/Metabolic | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
CE-Meloxicam | Sedor | Inflammatory/Metabolic | Captisol |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
LTP-O3FA | Omthera/AstraZeneca | Inflammatory/Metabolic | Captisol |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
anti-FcRN | Harbour | Inflammatory/Metabolic | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Tetragenics | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
CE-Budesonide | Sedor | Inflammatory/Metabolic | Captisol |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Teva | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Tizona | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | WuXi | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | xCella | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
NUC-101 | Nucorion | Infectious Disease | Other/NCE |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
SAGE-689 | SAGE | CNS | Captisol |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
IV Lamotrigine | CURx Pharma | CNS | Captisol |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
CE-Acetaminophen | Seelos | CNS | Captisol |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
PD-1 | Arcus | Oncology | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
EPOR Agonist | Viking | Blood Disorders | Other/NCE |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
CE-Ziprasodone | Beloteca | CNS | Captisol |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
NUC-202 | Nucorion | Infectious Disease | Other/NCE |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
DGAT-1 Inhibitor | Viking | Inflammatory/Metabolic | Other/NCE |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
H3 Receptor Antagonist | Seelos | Inflammatory/Metabolic | Other/NCE |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
CE-Cannabinoids | Vireo Health | Inflammatory/Metabolic | Captisol |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
Undisclosed | AiCuris GmBH | Infectious Disease | Captisol |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Teneobio | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
CRTH2 Antagonist | Seelos | Inflammatory/Metabolic | Other/NCE |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Merck KGaA | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
CE programs | Avion | Other/Undisclosed | Captisol |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | ARMO Biosciences | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Bluebird | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Boehringer Ingelheim | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Celgene | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Aptevo | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Amgen | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | ABBA | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | AbbVie | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Achaogen | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Alexo | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Ferring | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Five Prime Therapeutics | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Ono Pharmaceuticals | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Janssen | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Pfizer | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Seattle Genetics | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Surface Oncology | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
CE-program | Interventional Analgesix | Other/Undisclosed | Captisol |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Hanall Biopharma | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | F-Star | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Genmab | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Gilead | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Glenmark | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|
OmniAb | Symphogen | Other/Undisclosed | OmniAb |
Preclinical In Progress
|
Phase 1 Not Started
|
Phase 2 Not Started
|
Phase 3 or Regulatory Not Started
|
Approved Not Started
|